Clinical Trials Directory

Trials / Completed

CompletedNCT01567345

Intrathecal Morphine Administration Using Implantable Pump With Continuous or Programmable Flow

Comparison of Two Types of Intrathecal Morphine Administration by Pump for Analgesia in Cancer Patients With Failure of Conventional Analgesic Therapy.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Institut Cancerologie de l'Ouest · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to compare intrathecal morphine administration: using a pump with continuous or programmable flow.

Detailed description

Cancer is frequently associated with pain. In spite of recent improvements in cancer related pain treatment, incidence of cancerous chronic pain did not decrease. Indeed, 15 to 20% of patients are still suffering from intractable pain despite an optimal symptom management. Treatment of cancer pain is generally based on the WHO analgesic ladder according to 3 steps. Patients with advanced cancer are often treated at WHO step 3 analgesics, i.e. morphine and its derivatives, at high dosages. But increasing the dosage of opioids also leads to accentuation of their adverse events and the corresponding risks. At this stage of the disease, in patients with failure of conventional analgesic therapy, intrathecal injection of analgesics can be decided in order to relieve pain. 2 types of pumps allow intrathecal morphine administration : continuous or programmable flow. In this study, we want to compare the quality of analgesia obtained through these 2 flows.

Conditions

Interventions

TypeNameDescription
DEVICEImplantable pump with continuous flowInsertion of an implantable pump filled up with the analgesic solution. Connection of the catheter to the intrathecal space. Continuous morphine's flow is scheduled.
DEVICEImplantable pump with programmable flow.Insertion of an implantable pump filled up with the analgesic solution. Connection of the catheter to the intrathecal space. Programmable morphine's flow is scheduled.

Timeline

Start date
2009-01-14
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2012-03-30
Last updated
2024-08-02

Locations

6 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01567345. Inclusion in this directory is not an endorsement.